Orthopedic Bone Graft Substitute Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Allograft Market, Demineralized Bone Matrix Market, and 1 more
세계의 정형외과용 골이식편(BGS) 시장 규모는 2024년에 약 28억 3,000만 달러에 달했습니다. 이 시장은 4.1%의 CAGR로 확대하며, 2031년에는 약 37억 5,000만 달러에 달할 것으로 예측됩니다. 이 시장에는 정형외과, 외상, 재건 수술에 사용되는 다양한 유형의 골 정형외과용 골이식재가 포함됩니다.
COVID-19 팬데믹으로 인해 선택적 수술이 연기되면서 BGS의 매출은 감소했습니다. 그러나 시장은 2022년까지 강력하게 회복되어 안정적인 성장을 재개했습니다. 저침습적 기술이 기존 골이식술보다 합성골 및 DBM 기반 이식편의 채택을 촉진하고 있습니다. 고령화와 외상 증가로 인한 정형외과수술 증가가 시장 성장을 촉진하고 있습니다. 생체공학적 골이식재의 기술 발전은 이식 효율과 환자 결과를 개선하고 있습니다.
세계의 정형외과용 골이식편 시장에 대해 조사했으며, 시장의 개요와 시장 분석과 예측, 촉진요인과 억제요인, 경쟁 구도 등을 제공하고 있습니다.
목차
개요
- 세계의 정형외과용 골이식편시장 개요
- 경쟁 분석
- 시장 세분화
- 대상 지역
서론
시술 건수
- 정형외과적 골이식 수술
- 동종 이식 수술
- 탈회골 매트릭스 수술
- 합성 시술
시장 개요
시장 분석과 예측
- 정형외과용 골이식 대체품 시장 전체
- 동종 골이식 대체품 시장
- 탈회골 매트릭스 동종 이식 골이식 대체품 시장
- 합성 골이식 대체품 시장
건수 분석
- 동종 골이식 대체 건수 분석
- 탈회골 매트릭스 동종 이식 골이식편 건수 분석
- 인공 골이식편 건수 분석
촉진요인과 억제요인
경쟁 시장 점유율 분석
KSA
The global bone graft substitute (BGS) market was valued at approximately $2.83 billion in 2024 and is expected to grow at a CAGR of 4.1%, reaching approximately $3.75 billion by 2031. The market includes various types of bone graft substitutes used in orthopedic, trauma, and reconstructive surgeries.
The BGS market is segmented into:
- Allograft BGS
- Demineralized Bone Matrix (DBM) Allograft BGS
- Synthetic BGS
The market is further categorized based on indication type:
- Spine (Cervical, Thoracolumbar)
- Trauma (Non-union, Fresh Fracture)
- Large Joint Reconstruction (Hip, Knee)
- Craniomaxillofacial
- Oncology
- Foot Bone Reconstructions
Market Insights
- Unit Sales & Average Selling Prices
- Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031
- Recent Mergers & Acquisitions
- Competitive Landscape
- Company Profiles & Product Portfolios
Market Trends
- The COVID-19 pandemic caused a decline in BGS sales due to postponed elective surgeries. However, the market recovered strongly by 2022 and resumed steady growth.
- Minimally invasive techniques are driving the adoption of synthetic and DBM-based grafts over traditional bone grafting procedures.
- Rising orthopedic procedures due to an aging population and increasing trauma-related injuries are fueling market growth.
- Technological advancements in bioengineered bone grafts are increasing graft efficiency and patient outcomes.
Market Share Insights
Top Competitors in the Global Bone Graft Substitute Market (2024):
1 Medtronic
* Market leader due to a dominant share in the DBM and synthetic BGS segments.
* Grafton(R) - The first fiber-based DBM allograft BGS and one of the most widely used.
* MASTERGRAFT(R) - Synthetic BGS product line available in granules, moldable putty, flexible strip, and matrix EXT.
2 Stryker
* Second-largest competitor in the market.
* Offers multiple BGS products including Vitoss(TM), ALLOMATRIX(R), FUSIONFLEX(R), and PRO-STIM(R).
3 DePuy Synthes (Johnson & Johnson)
* Third-largest competitor in the BGS market.
* Competes with its DBX(R) DBM product line and chronOS(R) synthetic BGS.
Global Research Scope
* North America: United States, Canada
* Latin America: Brazil, Mexico, Chile, Colombia
* Western Europe: Germany, France, Italy, Spain, United Kingdom
* Central & Eastern Europe: Poland, Russia, Turkey
* Middle East: Saudi Arabia, UAE, Israel
* Asia Pacific: China, Japan, India, South Korea
* Africa: South Africa, Egypt, Nigeria
- Base Year: 2024
- Forecast Period: 2025-2031
- Historical Data: 2021-2023
Quantitative Coverage
- Market Size
- Market Shares
- Market Forecasts
- Market Growth Rates
- Units Sold
- Average Selling Prices
- Procedure Numbers
Qualitative Coverage
- COVID-19 Impact
- Market Growth Trends
- Market Limiters
- Competitive Analysis & SWOT for Top Competitors
- Mergers & Acquisitions
- Company Profiles
- Product Portfolios
- FDA Recalls
- Disruptive Technologies
- Disease Overviews
Data Sources
- Primary Interviews with Industry Leaders
- Government Physician Data
- Regulatory Data
- Hospital Private Data
- Import & Export Data
- iData Research Internal Database
TABLE OF CONTENT
- 4.1 Executive Summary
- 4.1.1 Global Orthopedic Bone Graft Substitute Market Overview
- 4.1.2 Competitive Analysis
- 4.1.3 Regions Included
- 4.2 Introduction
- 4.3 Procedure Numbers
- 4.3.1 Total Orthopedic Bone Grafting Procedures
- 4.3.2 Allograft Procedures
- 4.3.3 Demineralized Bone Matrix Procedures
- 4.3.4 Synthetic Procedures
- 4.4 Market Overview
- 4.4.1 By Segment
- 4.4.2 By Region
- 4.5 Market Analysis and Forecast
- 4.5.1 Total Orthopedic Bone Graft Substitute Market
- 4.5.2 Allograft Bone Graft Substitute Market
- 4.5.3 Demineralized Bone Matrix Allograft Bone Graft Substitute Market
- 4.5.4 Synthetic Bone Graft Substitute Market
- 4.5.4.1 Synthetic Bone Graft Substitute Market by Generation Type
- 4.6 Unit Analysis
- 4.6.1 Allograft Bone Graft Substitute Unit Analysis
- 4.6.1.1 Allograft Bone Graft Substitute Units Sold by Indication
- 4.6.1.1.1 Spine Allograft Bone Graft Substitute Units Sold
- 4.6.1.1.2 Trauma Allograft Bone Graft Substitute Units Sold
- 4.6.1.1.3 Large Joint Reconstruction Allograft Bone Graft Substitute Units Sold
- 4.6.2 Demineralized Bone Matrix Allograft Bone Graft Substitute Unit Analysis
- 4.6.2.1 Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold by Indication
- 4.6.2.1.1 Spine Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold
- 4.6.2.1.2 Trauma Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold
- 4.6.2.1.3 Large Joint Reconstruction Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold
- 4.6.3 Synthetic Bone Graft Substitute Unit Analysis
- 4.6.3.1 Synthetic Bone Graft Substitute Units Sold by Indication
- 4.6.3.1.1 Spine Synthetic Bone Graft Substitute Units Sold
- 4.6.3.1.2 Trauma Synthetic Bone Graft Substitute Units Sold
- 4.6.3.1.3 Large Joint Reconstruction Synthetic Bone Graft Substitute Units Sold
- 4.7 Drivers and Limiters
- 4.7.1 Market Drivers
- 4.7.2 Market Limiters
- 4.8 Competitive Market Share Analysis
